{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "A constipa\u00e7\u00e3o representa uma inflama\u00e7\u00e3o aguda e autolimitada da mucosa das vias a\u00e9reas superiores, que pode envolver uma ou todas de entre os seios perinasais, rinofaringe, orofaringe e laringe. \u00c1 comum ter-se pelo menos um epis\u00f3dio por ano. Os sintomas da constipa\u00e7\u00e3o, que podem incluir dor de garganta, crises esternutat\u00f3rias, congest\u00e3o nasal, rinorreia, cefaleias, mal-estar e febre baixa geralmente desaparecem dentro de alguns dias sem tratamento. O agente etiol\u00f3gico da maioria das constipa\u00e7\u00f5es \u00e9 o rinov\u00edrus. Embora n\u00e3o esteja associado letalidade, a constipa\u00e7\u00e3o \u00e9 associada com morbidade significativa. N\u00e3o existe vacina ou cura para a constipa\u00e7\u00e3o e, portanto, o seu tratamento est\u00e1 centrado em aliviar os sintomas. Esta revis\u00e3o Cochrane teve como objetivo sintetizar a evid\u00eancia existente sobre o benef\u00edcio cl\u00ednico de anti-histam\u00ednicos, utilizados em monoterapia, em compara\u00e7\u00e3o com placebo ou nenhum tratamento, em crian\u00e7as e em doentes adultos com constipa\u00e7\u00e3o. Foram inclu\u00eddos um total de 18 ensaios cl\u00ednicos aleatorizados, com um total de 4 342 participantes. Os principais resultados foram: 1) Anti-histam\u00ednicos t\u00eam um pequeno (dias um e dois de tratamento) efeito ben\u00e9fico a curto-prazo sobre a gravidade dos sintomas globais em doentes adultos, embora este efeito n\u00e3o esteja presente no m\u00e9dio a longo prazo; 2) Os anti-histam\u00ednicos foram associados com um efeito ben\u00e9fico n\u00e3o clinicamente relevante sobre os sintomas individuais (congest\u00e3o nasal, rinorreia e esternutos); 3) Os anti-histam\u00ednicos n\u00e3o est\u00e3o associados com um risco aumentado de efeitos adversos; 4) Nenhuma conclus\u00e3o pode ser feita sobre a efic\u00e1cia dos anti-histam\u00ednicos em popula\u00e7\u00f5es pedi\u00e1tricas. A nossa interpreta\u00e7\u00e3o dos resultados \u00e9 que a evid\u00eancia dispon\u00edvel \u00e9 insuficiente para apoiar a prescri\u00e7\u00e3o ou a compra de anti-histam\u00ednicos de venda-livre para aliviar os sintomas da constipa\u00e7\u00e3o sem componente al\u00e9rgico."
      ]
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "27285091",
  "DateCompleted": {
    "Year": "2017",
    "Month": "08",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "10",
    "Day": "23"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2016",
        "Month": "03",
        "Day": "31"
      }
    ],
    "Language": [
      "por"
    ],
    "ELocationID": [
      "10.20344/amp.7526"
    ],
    "Journal": {
      "ISSN": "1646-0758",
      "JournalIssue": {
        "Volume": "29",
        "Issue": "3",
        "PubDate": {
          "Year": "2016",
          "Month": "Mar"
        }
      },
      "Title": "Acta medica portuguesa",
      "ISOAbbreviation": "Acta Med Port"
    },
    "ArticleTitle": "[Analysis of the Cochrane Review: Antihistamines for the Common Cold. Cochrane Database Syst Rev. 2015;11:CD009345].",
    "Pagination": {
      "StartPage": "164",
      "EndPage": "167",
      "MedlinePgn": "164-7"
    },
    "Abstract": {
      "AbstractText": [
        "The common cold is an acute, self-limiting inflammation of the mucosa of the upper airways, which may involve one or all the sinuses, nasopharynx, oropharynx and larynx. It is common to have at least one episode per year. Common cold symptoms, which may include sore throat, sneezing, nasal congestion, runny nose, headache, malaise and mild fever usually disappear within a few days without treatment. The causative agent of most colds is rhinovirus. Although not associated with mortality, common cold is associated with significant morbidity. There is no vaccine or cure for common cold and, therefore, their treatment is centered on relieving the symptoms. This Cochrane review aimed to synthesize the existing evidence about the clinical benefit of antihistamines, used as monotherapy, compared with placebo or no treatment in children and adult patients with common cold. A total of 18 randomized clinical trials with 4342 participants were included. Main results were: 1) Antihistamines have a small (days one and two) beneficial effect in the short term on the severity of overall symptoms in adult patients, although this effect is not present in the medium to long term; 2) antihistamines were not associated with a clinically significant beneficial effect on the individual symptoms (nasal congestion, rhinorrhea, and sneezing); 3) Antihistamines are not associated with an increased risk of adverse effects; 4) No conclusion can be made about the effectiveness of antihistamines in pediatric populations. Our interpretation of the results is that the available evidence is insufficient to support the prescription or buying OTC antihistamines to relieve the symptoms of common cold without allergic component."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical and Experimental Medicine, Policlinico 'G. Martino'. University of Messina. Messina. Italy."
          }
        ],
        "LastName": "Sterrantino",
        "ForeName": "Carmel",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica. Faculdade Medicina. Universidade de Lisboa. Portugal. Centro de Estudos de Medicina Baseada na Evid\u00eancia. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal."
          }
        ],
        "LastName": "Duarte",
        "ForeName": "Gon\u00e7alo",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica. Faculdade Medicina. Universidade de Lisboa. Portugal. Centro de Estudos de Medicina Baseada na Evid\u00eancia. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal."
          }
        ],
        "LastName": "Costa",
        "ForeName": "Jo\u00e3o",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Servi\u00e7o de Farmacologia Cl\u00ednica. Faculdade de Medicina de Lisboa. Lisboa. Portugal. Centro Colaborador Portugu\u00eas da Rede Cochrane Iberoamericana. Lisboa. Portugal."
          }
        ],
        "LastName": "Vaz-Carneiro",
        "ForeName": "Ant\u00f3nio",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ],
    "VernacularTitle": "An\u00e1lise da Revis\u00e3o Cochrane: Antihistam\u00ednicos para a Constipa\u00e7\u00e3o. Cochrane Database Syst Rev. 2015;11:CD009345."
  },
  "MedlineJournalInfo": {
    "Country": "Portugal",
    "MedlineTA": "Acta Med Port",
    "NlmUniqueID": "7906803",
    "ISSNLinking": "0870-399X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Histamine Antagonists"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Histamine Antagonists"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Randomized Controlled Trials as Topic"
    }
  ]
}